Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Fuad Jubran, MD, holds the Jubran Endowed Chair in Cardiovascular Medicine, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, in the Sydell and Arnold Miller Family Heart & Vascular Institute. He is certified by the American Board of Internal Medicine and the American Board of Cardiology.
A native of Lebanon, Dr. Jubran completed his undergraduate work in biology and received his medical degree from the American University of Beirut. He remained there for his internship and residency in internal medicine then relocated to Ohio to become a cardiology resident at University Hospitals of Cleveland. Dr. Jubran was an associate professor at the American University Hospital until 1986.
Dr. Jubran was named to the Cleveland Clinic staff in 1986. He continues to have strong personal and professional ties to Lebanon and has a keen interest in promoting medical education in the Middle East. He is a founding member of the Cleveland Clinic International Leadership Board, Director of the Fuad Jubran Center for Middle East Medical Education and Director of the Rose Yabroudi Endowed Fund for Specialty Training of Young Women Medical Graduates from the Middle East, both at Cleveland Clinic. His other involvement at Cleveland Clinic includes chairing the Committee of Sabbagh International Preparatory Fellowship Program and serving as physician Director of Development for Middle East International Affairs. He also is co-chair of the Middle East Medical Assembly at the American University of Beirut.
During his long career at Cleveland Clinic, Dr. Jubran has served as Director of the Coronary Intensive Care Unit and Head of the Section of Coronary Intensive Care.
He has presented his clinical experience at medical conferences worldwide, including the American Heart Association Scientific Session, the Saudi Heart Association, Syrian Cardiovascular Symposium, the Mediterranean Associates of Cardiology, and the Al Ain International Cardiology Conference. He has authored or co-authored numerous articles in leading medical journals, including Critical Care Medicine, Chest and the Journal of the Saudi Heart Association, on topics related to new treatments for heart failure, managing acute myocardial infarction and cardiac critical care.
Dr. Jubran is a Fellow of the American College of Cardiology and the American College of Physicians.
intensive care, clinical cardiology
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/24/2014, Dr. Jubran has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.